Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| KOFFEX DM (SUCROSE FREE) | 15MG | SYRUP | Resolved | 2023-06-19 | 2023-07-06 | 195640 |
| CALMYLIN | 125MG 12.5MG 3.33MG | SYRUP | Resolved | 2023-06-20 | 2023-10-03 | 195769 |
| CALMYLIN | 125MG 12.5MG 3.33MG | SYRUP | Resolved | 2023-06-20 | 2023-07-05 | 195792 |
| CALMYLIN | 125MG 12.5MG 3.33MG | SYRUP | Resolved | 2023-06-20 | 2023-10-03 | 195836 |
| KOFFEX DM | 15MG | SYRUP | Resolved | 2023-06-26 | 2023-10-04 | 196380 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2023-07-04 | 2024-02-07 | 197195 |
| KOFFEX DM | 15MG | SYRUP | Resolved | 2023-08-03 | 2023-10-04 | 200882 |
| TEVA-COTRIDIN EXPECTORANT | 10MG 100MG 30MG 2MG | SYRUP | Actual shortage | 2023-12-07 | 2024-02-22 | 212714 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-08 | 2024-04-11 | 194138 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195609 |
| TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2017-03-10 | 2017-04-25 | 202 |
| TEVA-ATENOLOL/CHLORTHALIDONE | 25MG 100MG | TABLET | Resolved | 2017-03-13 | 2020-01-21 | 952 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 974 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2017-03-13 | 2019-05-28 | 983 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 997 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1026 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2017-03-13 | 2019-04-11 | 1035 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |